Status:
COMPLETED
Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Healthy
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
To evaluate the effects of a 14-day repeated dose of 150 mg bupropion (therapeutic dose) on cognitive and executive functions, behaviour and subjective feelings, after sleep deprivation in 12 healthy ...
Detailed Description
The aim of this controlled double-blind randomized 3-session cross-over designed study is to evaluate the effects of a single dose of 150 mg and a 14-day repeated dose of 300 mg bupropion (therapeutic...
Eligibility Criteria
Inclusion
- BMI between 20.0 and 25.00
- no smoker
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00285155
Start Date
November 1 2004
End Date
February 1 2006
Last Update
August 9 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique
Montpellier, France, 34295